- Latest on global search for coronavirus vaccine: Three candidates show early promise MSN Money
- Preliminary results from two leading vaccine trials show promise CBS Evening News
- Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial CNBC
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial The Lancet
- 7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine InvestorPlace
- View Full Coverage on Google News
Source: Google Finance – Market News